However, these TFH cells secrete significantly less IL-21 than other circulating CD4+ T cells [169] and associate with decreased serum IL-21 levels [170], suggesting a severe limitation of the expected anti-tumour functions of TFH cells in DLBCL (Figure 2, right). This evidence concerns the gene IL21 and diffuse large B-cell lymphoma.